These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 8207963

  • 1. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ, Lee YY, Pakkala S, de Vos S, Elstner E, Norman AW, Green J, Uskokovic M, Koeffler HP.
    Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
    Pakkala S, de Vos S, Elstner E, Rude RK, Uskokovic M, Binderup L, Koeffler HP.
    Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
    [Abstract] [Full Text] [Related]

  • 3. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y, Pike JW, Koeffler HP.
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [Abstract] [Full Text] [Related]

  • 4. Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines.
    de Vos S, Holden S, Heber D, Elstner E, Binderup L, Uskokovic M, Rude B, Chen DL, Le J, Cho SK, Koeffler HP.
    Prostate; 1997 May 01; 31(2):77-83. PubMed ID: 9140119
    [Abstract] [Full Text] [Related]

  • 5. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.
    Zhou JY, Norman AW, Lübbert M, Collins ED, Uskokovic MR, Koeffler HP.
    Blood; 1989 Jul 01; 74(1):82-93. PubMed ID: 2665845
    [Abstract] [Full Text] [Related]

  • 6. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.
    Cross HS, Farsoudi KH, Peterlik M.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan 01; 347(1):105-10. PubMed ID: 8446178
    [Abstract] [Full Text] [Related]

  • 7. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Jan 01; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 8. Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism.
    Zhou JY, Norman AW, Akashi M, Chen DL, Uskokovic MR, Aurrecoechea JM, Dauben WG, Okamura WH, Koeffler HP.
    Blood; 1991 Jul 01; 78(1):75-82. PubMed ID: 1648977
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
    Bouillon R, Allewaert K, Xiang DZ, Tan BK, van Baelen H.
    J Bone Miner Res; 1991 Oct 01; 6(10):1051-7. PubMed ID: 1796753
    [Abstract] [Full Text] [Related]

  • 10. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
    Elstner E, Lee YY, Hashiya M, Pakkala S, Binderup L, Norman AW, Okamura WH, Koeffler HP.
    Blood; 1994 Sep 15; 84(6):1960-7. PubMed ID: 8080998
    [Abstract] [Full Text] [Related]

  • 11. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 12. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 01; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 13. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
    Yoon JS, Kim JY, Park HK, Kim ES, Ahn KS, Yoon SS, Cho CG, Kim BK, Lee YY.
    Int J Oncol; 2008 Feb 01; 32(2):387-96. PubMed ID: 18202761
    [Abstract] [Full Text] [Related]

  • 14. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol.
    Rao LG, Sutherland MK, Reddy GS, Siu-Caldera ML, Uskokovic MR, Murray TM.
    Bone; 1996 Dec 01; 19(6):621-7. PubMed ID: 8968029
    [Abstract] [Full Text] [Related]

  • 15. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP, Hirji K, Itri L.
    Cancer Treat Rep; 1985 Dec 01; 69(12):1399-407. PubMed ID: 2416438
    [Abstract] [Full Text] [Related]

  • 16. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
    Siu-Caldera ML, Clark JW, Santos-Moore A, Peleg S, Liu YY, Uskoković MR, Sharma S, Reddy GS.
    J Steroid Biochem Mol Biol; 1996 Dec 01; 59(5-6):405-12. PubMed ID: 9010346
    [Abstract] [Full Text] [Related]

  • 17. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW, Zhou JY, Henry HL, Uskokovic MR, Koeffler HP.
    Cancer Res; 1990 Nov 01; 50(21):6857-64. PubMed ID: 2208153
    [Abstract] [Full Text] [Related]

  • 18. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
    Honda A, Nakashima N, Mori Y, Katsumata T, Ishizuka S.
    J Steroid Biochem Mol Biol; 1992 Jan 01; 41(1):109-12. PubMed ID: 1310414
    [Abstract] [Full Text] [Related]

  • 19. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
    Okuno S, Inaba M, Nishizawa Y, Morii H.
    Miner Electrolyte Metab; 1995 Jan 01; 21(1-3):211-6. PubMed ID: 7565452
    [Abstract] [Full Text] [Related]

  • 20. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
    Munker R, Kobayashi T, Elstner E, Norman AW, Uskokovic M, Zhang W, Andreeff M, Koeffler HP.
    Blood; 1996 Sep 15; 88(6):2201-9. PubMed ID: 8822940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.